Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-20

Clinical Trial Update: Low Dose Atropine Eye Drops in Myopic Egyptian Children [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating low-dose atropine eye drops for myopia progression in Egyptian children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • low-dose atropine eye drops (atropine)

Snippet

Sponsor: Ain Shams University | Conditions: Myopia Progression, Axial Length, Eye | Phase 2 | Status: UNKNOWN